These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 3479550)

  • 1. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects.
    Giros B; Gros C; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Vlaiculescu A; Costentin J; Lecomte JM
    J Pharmacol Exp Ther; 1987 Nov; 243(2):666-73. PubMed ID: 3479550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of endogenous enkephalins in locomotion evidenced by acetorphan, an "enkephalinase" inhibitor.
    Michael-Titus A; Preterre P; Giros B; Costentin J
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1062-6. PubMed ID: 3121843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.
    Lecomte JM; Costentin J; Vlaiculescu A; Chaillet P; Marcais-Collado H; Llorens-Cortes C; Leboyer M; Schwartz JC
    J Pharmacol Exp Ther; 1986 Jun; 237(3):937-44. PubMed ID: 3519939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiorphan and analogs: lack of correlation between potency to inhibit "enkephalinase A" in vitro and analgesic potency in vivo.
    Mendelsohn LG; Johnson BG; Scott WL; Frederickson RC
    J Pharmacol Exp Ther; 1985 Aug; 234(2):386-90. PubMed ID: 3894620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of enkephalin degradation attenuated stress-induced motor suppression (conditioned suppression of motility).
    Nabeshima T; Katoh A; Kameyama T
    J Pharmacol Exp Ther; 1988 Jan; 244(1):303-9. PubMed ID: 3422094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enkephalinase inhibitors and molecular study of the differences between active sites of enkephalinase and angiotensin-converting enzyme].
    Roques BP
    J Pharmacol; 1985; 16 Suppl 1():5-31. PubMed ID: 2993752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retro-thiorphan.
    Roques BP; Lucas-Soroca E; Chaillet P; Costentin J; Fournié-Zaluski MC
    Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3178-82. PubMed ID: 6304695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enkephalinase inhibition by thiorphan and subsequent response of ethanol, normorphine and enkephalins on mouse vas deferens.
    Blum K; Wallace JE; DeLallo L; Briggs AH
    Funct Neurol; 1986; 1(2):156-64. PubMed ID: 3301556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of enkephalinase inhibition in the living mouse, using [3H]acetorphan as a probe.
    De la Baume S; Brion F; Dam Trung Tuong M; Schwartz JC
    J Pharmacol Exp Ther; 1988 Nov; 247(2):653-60. PubMed ID: 3183961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantiomers of [R,S]-thiorphan: dissociation of analgesia from enkephalinase A inhibition.
    Scott WL; Mendelsohn LG; Cohen ML; Evans DA; Frederickson RC
    Life Sci; 1985 Apr; 36(13):1307-13. PubMed ID: 2984500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition.
    Patey G; De La Baume S; Schwartz JC; Gros C; Roques B; Fournie-Zaluski MC; Soroca-Lucas E
    Science; 1981 Jun; 212(4499):1153-5. PubMed ID: 7015510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analgesia after inhibition of enkephalin degradation.
    Kehl LJ
    J Am Dent Assoc; 1986 Feb; 112(2):181-3. PubMed ID: 2419379
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro and in vivo effects of thiorphan: an inhibitor of enkephalinase A.
    Chipkin RE; Iorio LC; Barnett A; Berger J; Billard W
    Adv Biochem Psychopharmacol; 1982; 33():235-42. PubMed ID: 6751031
    [No Abstract]   [Full Text] [Related]  

  • 14. Enkephalinase inhibitors attenuate naloxone-precipitated withdrawal syndrome.
    Dzoljic MR
    NIDA Res Monogr; 1986; 75():575-8. PubMed ID: 3123978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the enkephalin-metabolizing enzymes by the first systemically active mixed inhibitor prodrug RB 101 induces potent analgesic responses in mice and rats.
    Noble F; Soleilhac JM; Soroca-Lucas E; Turcaud S; Fournie-Zaluski MC; Roques BP
    J Pharmacol Exp Ther; 1992 Apr; 261(1):181-90. PubMed ID: 1560364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptidases involved in the inactivation of exogenous and endogenous enkephalins.
    Schwartz JC; de la Baume S; Yi CC; Chaillet P; Marcais-Collado H; Costentin J
    J Neural Transm Suppl; 1983; 18():235-43. PubMed ID: 6348211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of enkephalin degradation in rat plasma.
    Weinberger SB; Zafuto CE; Walker RC; Martinez JL
    NIDA Res Monogr; 1986; 75():263-6. PubMed ID: 3123942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies.
    Giros B; Gros C; Solhonne B; Schwartz JC
    Mol Pharmacol; 1986 Mar; 29(3):281-7. PubMed ID: 2869404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone-reversible antidiarrheal effects of enkephalinase inhibitors.
    Marçais-Collado H; Uchida G; Costentin J; Schwartz JC; Lecomte JM
    Eur J Pharmacol; 1987 Dec; 144(2):125-32. PubMed ID: 3481337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic inhibition of enkephalinase induces changes in the antinociceptive and locomotor effects of the enkephalinase inhibitor acetorphan in rats.
    Bousselmame R; Eustache M; Michael-Titus A; Costentin J
    Neuropharmacology; 1991 Aug; 30(8):865-70. PubMed ID: 1780043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.